To achieve size heterogeneity and impurity analysis of low molecular weight species of monoclonal antibodies and quantify the glycan occupancy. DCs) in terms of amino acid sequence, drug-to-antibody ratio (DAR) and post-translational modifications.
National Institute of Biologicals (NIB) Ministry of Health & Family Welfare, Government of India
To perform primary statutory function of quality control of biologicals e.g. recombinant products including therapeutic monoclonal antibodies like trastuzumab and rituximab used in cancer treatment etc. in accordance with provisions of Drugs & Cosmetics Act 1940 and Rule 1945 amended from time to time.